世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000036745

呼吸器疾患用ワクチンの世界市場規模調査・予測:タイプ別、年齢層別、感染別、流通チャネル別、および地域別の分析(2023年〜2030年)

Bizwit Research & Consulting LLP

Global Respiratory Disease Vaccine Market Size study & Forecast, by Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine) by Age Group (Pediatric, Adult), by Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Others), by Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others) and Regional Analysis, 2023-2030

発刊日 2023/10/20

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000036745

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

世界の呼吸器疾患用ワクチン市場は、2022年に約922億3,000万米ドルと評価され、2023年から2030年の予測期間にわたって1.21%を超える健全な成長率で成長すると予想されています。呼吸器疾患は、呼吸に関与する器官を含む呼吸器系に影響を与えます。呼吸器系は、酸素の摂取と二酸化炭素の体外への排出を担っています。さまざまな状態によって呼吸器系の正常な機能が妨げられ、呼吸器疾患が引き起こされる可能性があります。 呼吸器疾患ワクチン市場は、呼吸器疾患の有病率の上昇やワクチン開発のための研究開発活動の増加などの要因により拡大しています。

喘息、肺炎、結核などのさまざまな呼吸器疾患の有病率の上昇が市場の成長を推進しています。 たとえば、世界保健機関(WHO)の 2021 年世界結核報告書には、2021 年 10 月に結核症例のほとんどが東南アジア(43%)、アフリカ(25%)、西太平洋(18%)で発見されたと記載されています。一方、東地中海(8.3%)とヨーロッパ(2.3%)ではより少ない症例が発見されました。さらに、世界保健機関(WHO)が発表した統計によると、2020 年には世界中で約 1,000 万人が結核に罹患し、2021 年 10 月には約 150 万人が結核により死亡しました。さらに、2015 年の Statista によると、インド全土の高齢者の喘息症例数は900万人でしたが、2020年には1,070万人に増加し、2050年までに2,540万人に達すると予測されています。したがって、成長全体にわたる呼吸器疾患の有病率の上昇が市場の成長を推進しています。 さらに、ワクチン開発活動に対する政府の支援の増加と啓発プログラムの数の増加により、市場の成長に有利な機会が生まれています。ただし、呼吸器疾患用ワクチンの研究開発に伴う高額なコストにより、2023年から2030年の予測期間を通じて市場の成長が抑制されます。

世界の呼吸器疾患用ワクチン市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカが含まれます。北アメリカは、ワクチン開発のための高度な医療技術の利用可能性、研究開発プログラムの数の増加、官民企業による投資の増加、医療支出の増加により、2022年の市場を支配しました。一方、アジア太平洋地域は、対象疾患の有病率の上昇、医療費の増加、同地域でのワクチン開発を促進する政府の取り組みの強化などの要因により、大幅な成長を記録すると予測されています。

調査範囲

  • 調査企業
    ➣ GSK plc.
    ➣ Johnson & Johnson Services, Inc.
    ➣ Pfizer Inc.
    ➣ Sanofi- Aventis
    ➣ Serum Institute of India Pvt. Ltd.
    ➣ Sinovac Biotech Ltd
    ➣ Bavarian Nordic A/S
    ➣ Merck & Co., Inc.
    ➣ AstraZeneca plc
    ➣ Emergent BioSolutions Inc
  • 調査対象年
    ➣ 実績データ - 2020 - 2021
    ➣ 推定基準年 - 2022
    ➣ 予測期間 - 2023-2030

この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。

このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。

  • 市場セグメント
    ➣ タイプ別
      ◇ ウイルスワクチン
      ◇ 細菌ワクチン
      ◇ 混合ワクチン
    ➣ 年齢層別
      ◇ 小児
      ◇ 成人
    ➣ 感染別
      ◇ COVID-19(新型コロナウイルス感染症)
      ◇ インフルエンザ
      ◇ 呼吸器合胞体ウイルス(RSV)
      ◇ 肺炎
      ◇ その他
    ➣ 流通チャネル別
      ◇ 病院および小売薬局
      ◇ 政府のサプライヤー
      ◇ その他
    ➣ 地域別
       ◇ 北アメリカ
       ✓ アメリカ
       ✓ カナダ
       ◇ ヨーロッパ
       ✓ イギリス
       ✓ ドイツ
       ✓ フランス
       ✓ スペイン
       ✓ イタリア
       ✓ その他のヨーロッパ
       ◇ アジア太平洋地域
       ✓ 中国
       ✓ インド
       ✓ 日本
       ✓ オーストラリア
       ✓ 韓国
       ✓ その他のAPAC
       ◇ ラテンアメリカ
       ✓ ブラジル
       ✓ メキシコ
       ◇ 中東・アフリカ
       ✓ サウジアラビア
       ✓ 南アフリカ
       ✓ その他の中東・アフリカ

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Respiratory Disease Vaccine Market, by Region, 2020-2030 (USD Billion)
1.2.2. Respiratory Disease Vaccine Market, by Type, 2020-2030 (USD Billion)
1.2.3. Respiratory Disease Vaccine Market, by Age Group, 2020-2030 (USD Billion)
1.2.4. Respiratory Disease Vaccine Market, by Infection, 2020-2030 (USD Billion)
1.2.5. Respiratory Disease Vaccine Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Respiratory Disease Vaccine Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Respiratory Disease Vaccine Market Dynamics
3.1. Respiratory Disease Vaccine Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of respiratory disorders
3.1.1.2. Increasing research and development activities for vaccine development
3.1.2. Market Challenges
3.1.2.1. High initial cost of respiratory disease vaccine development
3.1.3. Market Opportunities
3.1.3.1. Increasing government support for the vaccine development activities
3.1.3.2. Rising number of disease awareness programs

Chapter 4. Global Respiratory Disease Vaccine Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Respiratory Disease Vaccine Market, by Type
5.1. Market Snapshot
5.2. Global Respiratory Disease Vaccine Market by Type, Performance - Potential Analysis
5.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
5.4.1. Viral Vaccine
5.4.2. Bacterial Vaccine
5.4.3. Combination Vaccine

Chapter 6. Global Respiratory Disease Vaccine Market, by Age Group
6.1. Market Snapshot
6.2. Global Respiratory Disease Vaccine Market by Age Group, Performance - Potential Analysis
6.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Age Group 2020-2030 (USD Billion)
6.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
6.4.1. Pediatric
6.4.2. Adult

Chapter 7. Global Respiratory Disease Vaccine Market, by Infection
7.1. Market Snapshot
7.2. Global Respiratory Disease Vaccine Market by Infection, Performance - Potential Analysis
7.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Infection 2020-2030 (USD Billion)
7.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
7.4.1. COVID-19
7.4.2. Influenza
7.4.3. Respiratory Syncytial Virus (RSV)
7.4.4. Pneumonia
7.4.5. Others

Chapter 8. Global Respiratory Disease Vaccine Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Respiratory Disease Vaccine Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
8.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
8.4.1. Hospital & Retail Pharmacies
8.4.2. Government Suppliers
8.4.3. Others

Chapter 9. Global Respiratory Disease Vaccine Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Respiratory Disease Vaccine Market, Regional Market Snapshot
9.4. North America Respiratory Disease Vaccine Market
9.4.1. U.S. Respiratory Disease Vaccine Market
9.4.1.1. Type breakdown estimates & forecasts, 2020-2030
9.4.1.2. Age Group breakdown estimates & forecasts, 2020-2030
9.4.1.3. Infection breakdown estimates & forecasts, 2020-2030
9.4.1.4. Distribution Channel breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Respiratory Disease Vaccine Market
9.5. Europe Respiratory Disease Vaccine Market Snapshot
9.5.1. U.K. Respiratory Disease Vaccine Market
9.5.2. Germany Respiratory Disease Vaccine Market
9.5.3. France Respiratory Disease Vaccine Market
9.5.4. Spain Respiratory Disease Vaccine Market
9.5.5. Italy Respiratory Disease Vaccine Market
9.5.6. Rest of Europe Respiratory Disease Vaccine Market
9.6. Asia-Pacific Respiratory Disease Vaccine Market Snapshot
9.6.1. China Respiratory Disease Vaccine Market
9.6.2. India Respiratory Disease Vaccine Market
9.6.3. Japan Respiratory Disease Vaccine Market
9.6.4. Australia Respiratory Disease Vaccine Market
9.6.5. South Korea Respiratory Disease Vaccine Market
9.6.6. Rest of Asia Pacific Respiratory Disease Vaccine Market
9.7. Latin America Respiratory Disease Vaccine Market Snapshot
9.7.1. Brazil Respiratory Disease Vaccine Market
9.7.2. Mexico Respiratory Disease Vaccine Market
9.8. Middle East & Africa Respiratory Disease Vaccine Market
9.8.1. Saudi Arabia Respiratory Disease Vaccine Market
9.8.2. South Africa Respiratory Disease Vaccine Market
9.8.3. Rest of Middle East & Africa Respiratory Disease Vaccine Market

Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. GSK plc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Johnson & Johnson Services, Inc.
10.3.3. Pfizer Inc.
10.3.4. Sanofi- Aventis
10.3.5. Serum Institute of India Pvt. Ltd.
10.3.6. Sinovac Biotech Ltd
10.3.7. Bavarian Nordic A/S
10.3.8. Merck & Co., Inc.
10.3.9. AstraZeneca plc
10.3.10. Emergent BioSolutions Inc

Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

List of Tables
TABLE 1. Global Respiratory Disease Vaccine Market, report scope
TABLE 2. Global Respiratory Disease Vaccine Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Respiratory Disease Vaccine Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 4. Global Respiratory Disease Vaccine Market estimates & forecasts by Age Group 2020-2030 (USD Billion)
TABLE 5. Global Respiratory Disease Vaccine Market estimates & forecasts by Infection 2020-2030 (USD Billion)
TABLE 6. Global Respiratory Disease Vaccine Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 7. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. U.S. Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. Canada Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. Canada Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. UK Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. UK Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. Germany Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. Germany Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. France Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. France Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Italy Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Italy Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. Spain Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. Spain Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. RoE Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. RoE Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. China Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. China Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. India Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. India Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. Japan Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. Japan Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. South Korea Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. South Korea Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. Australia Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. Australia Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. RoAPAC Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. RoAPAC Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Brazil Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Brazil Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. Mexico Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. Mexico Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. RoLA Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoLA Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. Saudi Arabia Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 69. South Africa Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. RoMEA Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Respiratory Disease Vaccine Market
TABLE 72. List of primary sources, used in the study of global Respiratory Disease Vaccine Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

List of figures
FIG 1. Global Respiratory Disease Vaccine Market, research methodology
FIG 2. Global Respiratory Disease Vaccine Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Respiratory Disease Vaccine Market, key trends 2022
FIG 5. Global Respiratory Disease Vaccine Market, growth prospects 2023-2030
FIG 6. Global Respiratory Disease Vaccine Market, porters 5 force model
FIG 7. Global Respiratory Disease Vaccine Market, pest analysis
FIG 8. Global Respiratory Disease Vaccine Market, value chain analysis
FIG 9. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Respiratory Disease Vaccine Market, regional snapshot 2020 & 2030
FIG 15. North America Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
FIG 16. Europe Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

この商品のレポートナンバー

0000036745

TOP